KORU Medical Systems (NASDAQ:KRMD) Announces Quarterly Earnings Results

KORU Medical Systems (NASDAQ:KRMD) released its earnings results on Tuesday. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.04, FiscalAI reports. The company had revenue of $11.57 million during the quarter, compared to the consensus estimate of $11.33 million. KORU Medical Systems had a negative return on equity of 10.63% and a negative net margin of 4.03%.

Here are the key takeaways from KORU Medical Systems’ conference call:

• Q3 revenue grew 11% to $11.6 million, though growth slowed as expected amid international timing effects. On a normalized basis, domestic core revenue grew 10% and international core grew 23%; management expects high-teens growth in Q4.
• Profitability and margins improved: gross margin rose 500 basis points year over year to 65.2%, and the company reported its second consecutive quarter of positive net income, alongside progress in adjusted EBITDA.
• KORU raised its 2026 outlook: revenue guidance is now $48 million–$48.5 million, gross margin guidance is 63%–64%, and the company expects positive full-year adjusted EBITDA and year-end cash above $8 million.
• Commercial and product initiatives broaden potential growth: new distribution agreements in Europe and Africa, three specialty pharmacies dispensing KORU products for RYSTIGGO home administration, and progress on drug programs and the Freedom360 pump could expand reach, though several opportunities remain subject to partner timelines and regulatory review.

KORU Medical Systems Stock Down 2.2%

NASDAQ KRMD traded down $0.07 during trading hours on Tuesday, hitting $3.16. 207,913 shares of the company were exchanged, compared to its average volume of 184,836. The firm has a market cap of $145.14 million, a price-to-earnings ratio of -79.00 and a beta of 0.47. The company has a 50 day moving average of $3.12 and a two-hundred day moving average of $3.96. KORU Medical Systems has a 52-week low of $2.86 and a 52-week high of $6.61.

Insider Activity

In related news, insider Adam Kalbermatten acquired 32,000 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The stock was acquired at an average price of $3.16 per share, for a total transaction of $101,120.00. Following the purchase, the insider owned 394,017 shares of the company’s stock, valued at $1,245,093.72. This represents a 8.84% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 18.50% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on KRMD shares. Craig Hallum reissued a “buy” rating and issued a $6.00 price objective on shares of KORU Medical Systems in a research note on Thursday, August 6th. Weiss Ratings downgraded shares of KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, September 29th. Zacks Research lowered shares of KORU Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Friday, October 30th. Finally, Wall Street Zen lowered shares of KORU Medical Systems from a “buy” rating to a “hold” rating in a report on Saturday. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $7.00.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc. develops, manufactures and markets portable infusion systems and related accessories for the home and alternate-site infusion markets. The company’s products are designed to support the controlled delivery of specialty drugs, including subcutaneous immunoglobulin (SCIG) therapies, through ambulatory infusion systems. KORU’s principal product platform is the Freedom Syringe Infusion System, which includes ambulatory syringe pumps such as the Freedom60, FreedomEdge and FreedomIQ, along with flow-control tubing sets and other disposable components.